HANNAH KYZAR: Open Payments
NPI 1750839379 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$628 in 34 payments from 13 companies in 2025. Trend: 2023 $1,034 · 2024 $844 · 2025 $628
Food & beverage: $628
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 9 | $160 |
| Dexcom, Inc. | 6 | $114 |
| PFIZER INC. | 4 | $78 |
| Novo Nordisk Inc | 3 | $60 |
| Lilly USA, LLC | 3 | $54 |
| Abbott Laboratories | 2 | $45 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $19 |
| Amgen Inc. | 1 | $19 |
| Exact Sciences Corporation | 1 | $18 |
| Antares Pharma, Inc. | 1 | $16 |
Products named: TRELEGY ELLIPTA, Dexcom G6 Transmitter, PREVNAR 20, FREESTYLE LIBRE 3, AREXVY, Ozempic, MOUNJARO, Wegovy.
Industry payments across AL — which companies pay providers there.
